Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients.
Diagnosis of Parkinson' disease (PD) carries a high misdiagnosis rate due to failure to recognize atypical parkinsonian disorders (APD). Usually by the time of diagnosis greater than 60% of the neurons in the substantia nigra are dead. Therefore, early detection would be beneficial so that ther...
Guardado en:
Autores principales: | Judith A Potashkin, Jose A Santiago, Bernard M Ravina, Arthur Watts, Alexey A Leontovich |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cea12965f5354884b9830decd12e6ed5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Neuropsychiatric disturbances in atypical parkinsonian disorders
por: Belvisi D, et al.
Publicado: (2018) -
The corticolimbic structural covariance network as an early predictive biosignature for cognitive impairment in Parkinson's disease
por: Yueh-Sheng Chen, et al.
Publicado: (2021) -
Identifying molecules as biosignatures with assembly theory and mass spectrometry
por: Stuart M. Marshall, et al.
Publicado: (2021) -
Automated, high accuracy classification of Parkinsonian disorders: a pattern recognition approach.
por: Andre F Marquand, et al.
Publicado: (2013) -
An enriched biosignature of gut microbiota-dependent metabolites characterizes maternal plasma in a mouse model of fetal alcohol spectrum disorder
por: Manjot S. Virdee, et al.
Publicado: (2021)